ArticleGenes2022

Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence.

Selena Mimmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.